(2003). Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut.
. T. MacDonald
First name
T.
Middle name
M.
Last name
MacDonald
(2004). Application of a propensity score to adjust for channelling bias with NSAIDs. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.946
. (2007). Drug treatment discontinuation and achievement of target blood pressure and cholesterol in United Kingdom primary care. Curr Med Res Opin. http://doi.org/10.1185/030079907x233124
. (2012). Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study. Bmj. http://doi.org/10.1136/bmj.e4447
. (2013). Pioglitazone and bladder cancer: a propensity score matched cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/j.1365-2125.2012.04325.x
. (2013). Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study. Bmj. http://doi.org/10.1136/bmj.f6954
. (2014). High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study. Heart. http://doi.org/10.1136/heartjnl-2013-304678
. (2014). Incidence and prevalence of multiple sclerosis in the UK 1990-2010: a descriptive study in the General Practice Research Database. J Neurol Neurosurg Psychiatry. http://doi.org/10.1136/jnnp-2013-305450
. (2014). Cardiovascular risk associated with sodium-containing medicines. Expert Opin Drug Saf. http://doi.org/10.1517/14740338.2014.970163
. (2015). Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis. Diabetologia. http://doi.org/10.1007/s00125-014-3456-9
.